Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    "Multiple endocrine neoplasia type 1"
Show Display Options
Rank Status Study
1 Enrolling by invitation Genetic Evaluation of Families With Endocrine Cancers
Conditions: Pancreatic Cancer;   Thymic Cancer;   Parathyroid Disease;   MEN1 Syndrome
Intervention: Genetic: Blood draw
2 Active, not recruiting Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
Conditions: Gastrinoma;   Glucagonoma;   Insulinoma;   Metastatic Gastrointestinal Carcinoid Tumor;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Pancreatic Polypeptide Tumor;   Pulmonary Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Regional Gastrointestinal Carcinoid Tumor;   Somatostatinoma;   WDHA Syndrome
Intervention: Drug: pazopanib hydrochloride
3 Unknown  Study Investigating MEN1 and SDHD in Familial Carcinoid Tumors
Condition: Carcinoid Neuroendocrine Cancer
Intervention:
4 Completed Cinacalcet to Treat Familial Primary Hyperparathyroidism
Conditions: Hypercalcemia;   Familial Primary Hyperparathyroidism
Interventions: Procedure: Parathyroid hormone testing;   Procedure: Serum calcium testing
5 Recruiting Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
Conditions: Neuroendocrine Tumors;   Von Hippel-Lindau Syndrome;   Hippel-Lindau Disease
Interventions: Drug: 68Gallium DOTATATE;   Procedure: Radio-guided surgery
6 Completed Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
Conditions: Neuroendocrine Tumors;   Carcinoid Tumor
Intervention: Drug: Quarfloxin
7 Completed Capecitabine and Temozolomide for Neuroendocrine Cancers
Condition: Neuroendocrine Tumors
Interventions: Drug: Capecitabine;   Drug: Temozolomide

Indicates status has not been verified in more than two years